Silver Book Fact

A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment savings.

Investment in Research Saves Lives and Money. http://www.researchamerica.org/advocacy/investment.html. Published 2005

Reference

Title
Investment in Research Saves Lives and Money
Publisher
Research!America
Publication Date
Published 2005
Authors
Research!America
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Five-year Relative Survival (%) during Three Time Periods by Cancer Site  
  • Estimated Number of Cancer Survivors in the United States From 1975 to 2012  
  • “Among women age 65 and over, the percentage who had a mammogram within the preceding 2 years almost tripled from 23% in 1987 to 64% in 2005.”  
  • The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.